# Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

> **NCT00092703** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 6000 (—)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** MK0663, etoricoxib
- **DRUG:** Comparator: Diclofenac sodium

## Key facts

- **NCT ID:** NCT00092703
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06-27
- **Primary completion:** 2003-11-01
- **Final completion:** 2003-11-01
- **Target enrollment:** 6000 (—)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092703, "Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00092703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*